Bajaj Finance shares fall 7% after Q4 results. Should you buy, sell or hold?

Motilal Oswal downgraded the stock to neutral with a target price of Rs 7,800 saying that the management's guidance for FY25 is below its long-term guidance on multiple metrics such as AUM growth, credit costs, RoA, and RoE.

Shares of Dalal Street's old warhorse on Friday fell up to Rs 6,790 on BSE as investors were left unimpressed with its Q4 results and worried that it could be even weaker.

Motilal Oswal downgraded the stock to neutral with a target price of Rs 7,800 saying that the management's guidance for FY25 is below its long-term guidance on multiple metrics such as AUM growth, credit costs, RoA, and RoE.

"Bajaj Finance's key product segments (until now) have been the secular growth segments. However, its foray into multiple newer products such as cars, tractors, CVs, and potentially MFI, could (in future) make its growth vulnerable to cyclicality despite having a well-diversified product mix," Motilal said.

UBS has maintained a sell rating with a target price of Rs 6,800 while highlighting elevated credit costs and weakened product mix in the quarter. Macquarie has maintained a neutral call with a target price of Rs 8,100.

Trading at 4.0x FY26E P/BV and 20x P/E, a trigger for the stock in the near term could be if RBI revokes its ban on 'E-com' and 'Insta EMI Card'. The company has addressed the deficiencies in the process that led to the RBI embargo, and has formally requested the regulator to lift the ban.

The management has given guidance for FY25 AUM growth of 26-28% and RoA of 4.6-4.8% of AAUM, with profitability improving in the second half as the first half will see some moderation in NIM on account of elevated borrowing cost.

“To reflect the Q4 developments and management commentary on future outlook, we adjust our estimates leading to a 3% cut in FY25E PAT, albeit a 1% increase in FY27E PAT. We reiterate our buy rating on the stock, with unchanged Mar-25 target price of Rs 9,000 per share, implying FY26E consolidated P/BV of 5.1x,” Emkay said.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?